Table of Content

1 Neuraminidase Inhibitor Market Overview
1.1 Product Overview and Scope of Neuraminidase Inhibitor
1.2 Neuraminidase Inhibitor Segment by Type
1.2.1 Global Neuraminidase Inhibitor Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Laninamivir
1.3 Neuraminidase Inhibitor Segment by Application
1.3.1 Neuraminidase Inhibitor Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 Others
1.4 Global Neuraminidase Inhibitor Market Size Estimates and Forecasts
1.4.1 Global Neuraminidase Inhibitor Revenue 2016-2027
1.4.2 Global Neuraminidase Inhibitor Sales 2016-2027
1.4.3 Neuraminidase Inhibitor Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neuraminidase Inhibitor Market Competition by Manufacturers
2.1 Global Neuraminidase Inhibitor Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neuraminidase Inhibitor Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neuraminidase Inhibitor Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neuraminidase Inhibitor Manufacturing Sites, Area Served, Product Type
2.5 Neuraminidase Inhibitor Market Competitive Situation and Trends
2.5.1 Neuraminidase Inhibitor Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuraminidase Inhibitor Players Market Share by Revenue
2.5.3 Global Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neuraminidase Inhibitor Retrospective Market Scenario by Region
3.1 Global Neuraminidase Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Neuraminidase Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Neuraminidase Inhibitor Market Facts & Figures by Country
3.3.1 North America Neuraminidase Inhibitor Sales by Country
3.3.2 North America Neuraminidase Inhibitor Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neuraminidase Inhibitor Market Facts & Figures by Country
3.4.1 Europe Neuraminidase Inhibitor Sales by Country
3.4.2 Europe Neuraminidase Inhibitor Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuraminidase Inhibitor Market Facts & Figures by Region
3.5.1 Asia Pacific Neuraminidase Inhibitor Sales by Region
3.5.2 Asia Pacific Neuraminidase Inhibitor Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neuraminidase Inhibitor Market Facts & Figures by Country
3.6.1 Latin America Neuraminidase Inhibitor Sales by Country
3.6.2 Latin America Neuraminidase Inhibitor Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuraminidase Inhibitor Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuraminidase Inhibitor Sales by Country
3.7.2 Middle East and Africa Neuraminidase Inhibitor Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Neuraminidase Inhibitor Historic Market Analysis by Type
4.1 Global Neuraminidase Inhibitor Sales Market Share by Type (2016-2021)
4.2 Global Neuraminidase Inhibitor Revenue Market Share by Type (2016-2021)
4.3 Global Neuraminidase Inhibitor Price by Type (2016-2021)

5 Global Neuraminidase Inhibitor Historic Market Analysis by Application
5.1 Global Neuraminidase Inhibitor Sales Market Share by Application (2016-2021)
5.2 Global Neuraminidase Inhibitor Revenue Market Share by Application (2016-2021)
5.3 Global Neuraminidase Inhibitor Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Gilead Sciences Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 F. Hoffman-La Roche
6.3.1 F. Hoffman-La Roche Corporation Information
6.3.2 F. Hoffman-La Roche Description and Business Overview
6.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.3.4 F. Hoffman-La Roche Product Portfolio
6.3.5 F. Hoffman-La Roche Recent Developments/Updates
6.4 BioCryst
6.4.1 BioCryst Corporation Information
6.4.2 BioCryst Description and Business Overview
6.4.3 BioCryst Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BioCryst Product Portfolio
6.4.5 BioCryst Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Daiichi Sankyo Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates

7 Neuraminidase Inhibitor Manufacturing Cost Analysis
7.1 Neuraminidase Inhibitor Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuraminidase Inhibitor
7.4 Neuraminidase Inhibitor Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuraminidase Inhibitor Distributors List
8.3 Neuraminidase Inhibitor Customers

9 Neuraminidase Inhibitor Market Dynamics
9.1 Neuraminidase Inhibitor Industry Trends
9.2 Neuraminidase Inhibitor Growth Drivers
9.3 Neuraminidase Inhibitor Market Challenges
9.4 Neuraminidase Inhibitor Market Restraints

10 Global Market Forecast
10.1 Neuraminidase Inhibitor Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuraminidase Inhibitor by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Type (2022-2027)
10.2 Neuraminidase Inhibitor Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuraminidase Inhibitor by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Application (2022-2027)
10.3 Neuraminidase Inhibitor Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuraminidase Inhibitor by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neuraminidase Inhibitor Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neuraminidase Inhibitor Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Neuraminidase Inhibitor Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neuraminidase Inhibitor Covered in This Study
Table 5. Global Neuraminidase Inhibitor Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Neuraminidase Inhibitor Sales Share by Manufacturers (2016-2021)
Table 7. Global Neuraminidase Inhibitor Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neuraminidase Inhibitor Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neuraminidase Inhibitor Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neuraminidase Inhibitor Manufacturing Sites and Area Served
Table 11. Manufacturers Neuraminidase Inhibitor Product Type
Table 12. Global Neuraminidase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neuraminidase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuraminidase Inhibitor as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neuraminidase Inhibitor Sales by Region (2016-2021) & (K Units)
Table 16. Global Neuraminidase Inhibitor Sales Market Share by Region (2016-2021)
Table 17. Global Neuraminidase Inhibitor Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neuraminidase Inhibitor Sales by Country (2016-2021) & (K Units)
Table 19. North America Neuraminidase Inhibitor Sales Market Share by Country (2016-2021)
Table 20. North America Neuraminidase Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neuraminidase Inhibitor Revenue Market Share by Country (2016-2021)
Table 22. Europe Neuraminidase Inhibitor Sales by Country (2016-2021) & (K Units)
Table 23. Europe Neuraminidase Inhibitor Sales Market Share by Country (2016-2021)
Table 24. Europe Neuraminidase Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neuraminidase Inhibitor Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neuraminidase Inhibitor Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Neuraminidase Inhibitor Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neuraminidase Inhibitor Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neuraminidase Inhibitor Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neuraminidase Inhibitor Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Neuraminidase Inhibitor Sales Market Share by Country (2016-2021)
Table 32. Latin America Neuraminidase Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neuraminidase Inhibitor Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neuraminidase Inhibitor Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Neuraminidase Inhibitor Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neuraminidase Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neuraminidase Inhibitor Revenue Market Share by Country (2016-2021)
Table 38. Global Neuraminidase Inhibitor Sales (K Units) by Type (2016-2021)
Table 39. Global Neuraminidase Inhibitor Sales Market Share by Type (2016-2021)
Table 40. Global Neuraminidase Inhibitor Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neuraminidase Inhibitor Revenue Share by Type (2016-2021)
Table 42. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2016-2021)
Table 43. Global Neuraminidase Inhibitor Sales (K Units) by Application (2016-2021)
Table 44. Global Neuraminidase Inhibitor Sales Market Share by Application (2016-2021)
Table 45. Global Neuraminidase Inhibitor Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neuraminidase Inhibitor Revenue Share by Application (2016-2021)
Table 47. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Neuraminidase Inhibitor Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Neuraminidase Inhibitor Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Gilead Sciences Corporation Information
Table 54. Gilead Sciences Description and Business Overview
Table 55. Gilead Sciences Neuraminidase Inhibitor Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Gilead Sciences Neuraminidase Inhibitor Product
Table 57. Gilead Sciences Recent Developments/Updates
Table 58. F. Hoffman-La Roche Corporation Information
Table 59. F. Hoffman-La Roche Description and Business Overview
Table 60. F. Hoffman-La Roche Neuraminidase Inhibitor Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. F. Hoffman-La Roche Neuraminidase Inhibitor Product
Table 62. F. Hoffman-La Roche Recent Developments/Updates
Table 63. BioCryst Corporation Information
Table 64. BioCryst Description and Business Overview
Table 65. BioCryst Neuraminidase Inhibitor Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. BioCryst Neuraminidase Inhibitor Product
Table 67. BioCryst Recent Developments/Updates
Table 68. Daiichi Sankyo Corporation Information
Table 69. Daiichi Sankyo Description and Business Overview
Table 70. Daiichi Sankyo Neuraminidase Inhibitor Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Daiichi Sankyo Neuraminidase Inhibitor Product
Table 72. Daiichi Sankyo Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Neuraminidase Inhibitor Distributors List
Table 76. Neuraminidase Inhibitor Customers List
Table 77. Neuraminidase Inhibitor Market Trends
Table 78. Neuraminidase Inhibitor Growth Drivers
Table 79. Neuraminidase Inhibitor Market Restraints
Table 80. Global Neuraminidase Inhibitor Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Neuraminidase Inhibitor Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Neuraminidase Inhibitor Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Neuraminidase Inhibitor Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Neuraminidase Inhibitor Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Neuraminidase Inhibitor Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Neuraminidase Inhibitor Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Neuraminidase Inhibitor Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Neuraminidase Inhibitor Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuraminidase Inhibitor
Figure 2. Global Neuraminidase Inhibitor Market Share by Type in 2020 & 2027
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Laninamivir Product Picture
Figure 7. Global Neuraminidase Inhibitor Market Share by Application in 2020 & 2027
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Retail Stores
Figure 11. Others
Figure 12. Global Neuraminidase Inhibitor Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Neuraminidase Inhibitor Market Size 2016-2027 (US$ Million)
Figure 14. Global Neuraminidase Inhibitor Sales 2016-2027 (K Units)
Figure 15. Global Neuraminidase Inhibitor Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Neuraminidase Inhibitor Sales Share by Manufacturers in 2020
Figure 17. Global Neuraminidase Inhibitor Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Neuraminidase Inhibitor Players: Market Share by Revenue in 2020
Figure 19. Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Neuraminidase Inhibitor Sales Market Share by Region (2016-2021)
Figure 21. Global Neuraminidase Inhibitor Sales Market Share by Region in 2020
Figure 22. Global Neuraminidase Inhibitor Revenue Market Share by Region (2016-2021)
Figure 23. Global Neuraminidase Inhibitor Revenue Market Share by Region in 2020
Figure 24. U.S. Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Neuraminidase Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Neuraminidase Inhibitor by Type (2016-2021)
Figure 49. Sales Market Share of Neuraminidase Inhibitor by Application (2016-2021)
Figure 50. Sales Market Share of Neuraminidase Inhibitor by Application in 2020
Figure 51. Revenue Share of Neuraminidase Inhibitor by Application (2016-2021)
Figure 52. Revenue Share of Neuraminidase Inhibitor by Application in 2020
Figure 53. Manufacturing Cost Structure of Neuraminidase Inhibitor
Figure 54. Manufacturing Process Analysis of Neuraminidase Inhibitor
Figure 55. Neuraminidase Inhibitor Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed